Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) benefit from innovative treatments for obesity and diabetes. Start Your ...

Novo and Valo originally partnered in September 2023 in an agreement to develop up to 11 drugs. With the expanded agreement, ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...

The health benefits of time-restricted eating go beyond weight loss and may be most prominent in patients already with ...

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...

WATERLOO, Iowa. (KWWL) - After two years at KWWL, Lilly Cederdahl signed off for her final time Wednesday. From covering county fairs to breaking news, to tracking morning commute, she said it's been ...

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

SHENZHEN — The South China metropolis of Shenzhen, Guangdong province, recently hosted a series of exhibitions, attracting ...